UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC–MS/MS-Based Assay

Analytical chemistry (Washington), 2018-08, Vol.90 (15), p.9395-9402

2018

Volltextzugriff (PDF)

Treatment with Edoxaban Attenuates Acute Stroke Severity in Mice by Reducing Blood–Brain Barrier Damage and Inflammation

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9893

2021

Volltextzugriff (PDF)

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach

Cardiovascular drugs and therapy, 2024-08, Vol.38 (4), p.747-756

2024

Volltextzugriff (PDF)

Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study

Drugs & aging, 2023-02, Vol.40 (2), p.153-164

2023

Volltextzugriff (PDF)

The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model

Frontiers in physiology, 2021-01, Vol.11, p.629421

2021

Volltextzugriff (PDF)

Drug–Drug Interactions with Direct Oral Anticoagulants

Clinical pharmacokinetics, 2020-08, Vol.59 (8), p.967-980

2020

Volltextzugriff (PDF)

Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay

Cancers, 2020-07, Vol.12 (7), p.1897

2020

Volltextzugriff (PDF)

Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity

대한뇌졸중학회지, 2022, 24(1), 20, pp.88-97

2022

Volltextzugriff (PDF)

Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial

Trials, 2020-06, Vol.21 (1), p.584-2, Article 584

2020

Volltextzugriff (PDF)

Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue

Pharmaceutics, 2022-03, Vol.14 (4), p.762

2022

Volltextzugriff (PDF)

Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways

BMC pharmacology & toxicology, 2019-08, Vol.20 (1), p.53-6, Article 53

2019

Volltextzugriff (PDF)

Given the Data of Hommers and Colleagues, Valproic Acid Is Not an Unequivocal Inducer of Clozapine Metabolism

Journal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.419-420

2019

Volltextzugriff (PDF)

Microdosing drugs: a versatile technique to detect and assess drug-drug interactions

Expert opinion on drug metabolism & toxicology, 2020-06, Vol.16 (6), p.447-448

2020

Volltextzugriff (PDF)

Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy

Cardiovascular research, 2022-06, Vol.118 (7), p.1728-1741

2022

Volltextzugriff (PDF)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Clinical pharmacokinetics, 2020-12, Vol.59 (12), p.1647-1647

2020

Volltextzugriff (PDF)

Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 Activity

Journal of clinical pharmacology, 2021-06, Vol.61 (6), p.789-798

2021

Volltextzugriff (PDF)

Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug–Drug Interactions with Potential Perpetrator Drugs

Clinical pharmacokinetics, 2019-09, Vol.58 (9), p.1155-1163

2019

Volltextzugriff (PDF)

Prolonged‐Release Tacrolimus Is Less Susceptible to Interaction With the Strong CYP3A Inhibitor Voriconazole in Healthy Volunteers

Clinical pharmacology and therapeutics, 2019-12, Vol.106 (6), p.1290-1298

2019

Volltextzugriff (PDF)

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

Clinical pharmacokinetics, 2024-04, Vol.63 (4), p.469-481

2024

Volltextzugriff (PDF)

Perpetrator effects of ciclosporin (P‐glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers

British journal of clinical pharmacology, 2019-07, Vol.85 (7), p.1528-1537

2019

Volltextzugriff (PDF)

Therapeutic drug monitoring of osimertinib in non‐small cell lung cancer and short bowel syndrome: A case report

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.344-349

2024

Volltextzugriff (PDF)

CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults

Clinical pharmacokinetics, 2023-09, Vol.62 (9), p.1305-1314

2023

Volltextzugriff (PDF)

Bioanalysis of selinexor in mouse plasma micro-samples utilizing UPLC-MS/MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2021-06, Vol.1176, p.122781, Article 122781

2021

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(102)
Japanisch
(9)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC–MS/MS-Based Assay

Treatment with Edoxaban Attenuates Acute Stroke Severity in Mice by Reducing Blood–Brain Barrier Damage and Inflammation

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach

Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study

The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model

Drug–Drug Interactions with Direct Oral Anticoagulants

Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay

Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity

Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial

Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways

Given the Data of Hommers and Colleagues, Valproic Acid Is Not an Unequivocal Inducer of Clozapine Metabolism

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

Microdosing drugs: a versatile technique to detect and assess drug-drug interactions

Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 Activity

Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug–Drug Interactions with Potential Perpetrator Drugs

Prolonged‐Release Tacrolimus Is Less Susceptible to Interaction With the Strong CYP3A Inhibitor Voriconazole in Healthy Volunteers

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

Perpetrator effects of ciclosporin (P‐glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers

Therapeutic drug monitoring of osimertinib in non‐small cell lung cancer and short bowel syndrome: A case report

CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults

Bioanalysis of selinexor in mouse plasma micro-samples utilizing UPLC-MS/MS

Suchergebnisse filtern